Evidence map›Paper›PMID 30732215›Full record

Observational studyMedicine2019

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.

Takeji Umemura, Satoru Joshita, Soichiro Shibata, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Eiji Tanaka

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Takeji UmemuraDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Satoru JoshitaDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Soichiro ShibataDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Ayumi SugiuraDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Tomoo YamazakiDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Naoyuki FujimoriDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Akihiro MatsumotoDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Eiji TanakaDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although renal impairment is a frequent complication in cirrhosis that is associated with a poor prognosis, little has been reported on the clinical significance of renal impairment in cirrhosis in Japan. This retrospective study assessed the impact of renal impairment on mortality in Japanese cirrhosis patients taking conventional diuretics.A total of 157 patients with cirrhosis receiving diuretic treatment were evaluated for the presence and status of renal impairment, defined as an increase in serum creatinine of ≥ 0.3 mg/dL or by ≥ 50%, and then classified according to the International Club of Ascites (ICA)-Acute Kidney Injury (AKI) staging system.Eighty of 157 (51%) patients fulfilled the criteria for renal impairment. Thirty-four (43%) patients had ICA-AKI stage 1, 32 (40%) stage 2, and 14 (18%) stage 3. Multivariate analysis revealed female gender (hazard ratio [HR] = 0.407, 95% confidence interval = 0.193-0.857; P = .018), ALT ≥35 IU/L (HR = 3.841, 95% confidence interval = 1.785-8.065; P = .001), and the presence of renal impairment (HR = 4.275, 95% confidence interval = 1.962-9.312; P < .001) as independent factors significantly increasing the risk of mortality. Cumulative survival rates increased significantly with ICA-AKI stage (log-rank test, P = .009).Renal impairment was a predictive marker of mortality in Japanese patients with cirrhosis. Stratification according to ICA-AKI criteria of kidney function impairment may be a good prognostic indicator of cirrhosis outcome.

Indexed as

Acute Kidney InjuryAgedCreatinineFemaleHumansLiver CirrhosisMaleMiddle AgedMultivariate AnalysisPrognosisRetrospective StudiesRisk FactorsSex FactorsSurvival RateCreatinine

Identifiers

PMID30732215
PMCPMC6380877
OpenAlexW2913476787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.